首页> 外文期刊>The Lancet >Oxidative-phosphorylation defects in liver of patients with Wilson's disease.
【24h】

Oxidative-phosphorylation defects in liver of patients with Wilson's disease.

机译:威尔逊氏病患者肝脏中的氧化磷酸化缺陷。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Wilson's disease (WD) is caused by mutations in a P-type ATPase and is associated with copper deposition in liver and brain. The WD protein is present in the trans-Golgi network and may also be imported into mitochondria. The WD protein functions as a P-type copper transporting ATPase in the Golgi but any action in mitochondria is at present unknown. METHODS: We studied mitochondrial function and aconitase activity in WD liver tissue and compared the results with those in a series of healthy controls and patients without WD. FINDINGS: There was evidence of severe mitochondrial dysfunction in the livers of patients with WD. Enzyme activities were decreased as follows: complex I by 62%, complex II+III by 52%, complex IV by 33%, and aconitase by 71%. These defects did not seem to be secondary to penicillamine use, cholestasis, or poor hepatocellular synthetic function. INTERPRETATION: The results show that there is a defect of energy metabolism in WD. The pattern of enzyme defects suggests that free-radical formation and oxidative damage, probably mediated via mitochondrial copper accumulation, are important in WD pathogenesis. These results provide a rationale for a study of the use of antioxidants in WD.
机译:背景:威尔逊病(WD)是由P型ATP酶的突变引起的,并且与肝脏和大脑中的铜沉积有关。 WD蛋白存在于反高尔基体网络中,也可以导入线粒体中。 WD蛋白在高尔基体中起P型铜转运ATPase的作用,但目前对线粒体的任何作用尚不清楚。方法:我们研究了WD肝组织中的线粒体功能和乌头酸酶活性,并将其与一系列健康对照和无WD患者的结果进行了比较。结论:有证据表明WD患者肝脏中存在严重的线粒体功能障碍。酶活性降低如下:复合物I降低62%,复合物II + III降低52%,复合物IV降低33%,乌头酸酶降低71%。这些缺陷似乎不是由于使用青霉素,胆汁淤积或肝细胞合成功能差所致。解释:结果表明WD中存在能量代谢缺陷。酶缺陷的模式表明,自由基的形成和氧化损伤,可能是通过线粒体铜积累介导的,在WD发病机理中很重要。这些结果为研究WD中抗氧化剂的使用提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号